Labesfal's Mg injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hisun's kanamycin injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
MSN's moxifloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
ViiV Healthcare's abacavir/lamivudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hetero's paediatric lopinavir/ritonavir tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Questions and answers on DTG use in women of childbearing age
M
On 18 May 2018, WHO has issued a web statement signalling a potential risk of neural tube defects in infants born to women who were taking dolutegravir (DTG) at the time of conception.